Recent advances in understanding the pathogenesis and biological treatment of multiple sclerosis.
In: Bratislava Medical Journal / Bratislavské Lekárske Listy, Jg. 124 (2023-12-01), Heft 12, S. 903-906
Online
academicJournal
Zugriff:
Multiple sclerosis is the most common demyelinating disease that develops in genetically predisposed individuals through various immunopathological mechanisms induced by environmental factors, especially viral infections. Th1, Th17, γδ T cells, activated macrophages, MAIT cells, and proinflammatory cytokines, particularly IFN-γ, TNF, IL-17, and GM-CSF, are the principal pathological players whose activities cause damage to the white matter. Furthermore, a recently identified subset of CD4+ T cells has been found to migrate directly to the brain cortex and cause damage to neurons. In 2022, a new mechanism was discovered in addition to these processes. It was shown that molecular mimicry between the EBNA-1 antigen of the Epstein-Barr virus and the GlialCAM molecule of glial cells forms the basis that triggers the entire pathological process. EBV is a highly B cell-tropic human herpesvirus that placed B cells at the centre of our attention. As a result, we must down-regulate their numbers using anti-CD20 monoclonal antibodies to treat such patients (Tab. 1, Fig. 1, Ref. 37). Text in PDF www.elis.sk [ABSTRACT FROM AUTHOR]
Titel: |
Recent advances in understanding the pathogenesis and biological treatment of multiple sclerosis.
|
---|---|
Autor/in / Beteiligte Person: | BUC, Milan |
Link: | |
Zeitschrift: | Bratislava Medical Journal / Bratislavské Lekárske Listy, Jg. 124 (2023-12-01), Heft 12, S. 903-906 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0006-9248 (print) |
DOI: | 10.4149/BLL_2023_143 |
Schlagwort: |
|
Sonstiges: |
|